A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2004
11/10/2004	EP1474121A2 Small molecule antagonists of bcl2 family proteins
11/10/2004	EP1474067A2 One dose vaccination with i mycoplasma hyopneumoniae /i
11/10/2004	EP1297119B1 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
11/10/2004	EP1267897B1 Treatment of congestive heart failure by pretreated autologous blood
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1259515B1 Thienopyridine derivatives and their use as anti-inflammatory agents
11/10/2004	EP1248833A4 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition
11/10/2004	EP1240172B1 New aminopropylphosphinic acids
11/10/2004	EP1144389B1 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoicacid]calcium salt
11/10/2004	EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/10/2004	EP1077930B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/10/2004	EP1027043B1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
11/10/2004	EP1017384B1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
11/10/2004	EP0929544B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1545551A Human monoclonal antibody against hepatitis C virus E2 glycoprotein
11/10/2004	CN1545548A Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
11/10/2004	CN1545515A 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative
11/10/2004	CN1545512A Rapamycin dialdehydes
11/10/2004	CN1545510A Quinazoline derivatives as alpha-1 adrenergic antagonists
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545422A Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingred
11/10/2004	CN1545421A Pharmaceutical compositions of drugs and neutralized acidic polymers
11/10/2004	CN1545418A Method of increasing the presence of glutathione in cells
11/10/2004	CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/10/2004	CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas
11/10/2004	CN1544088A Immediate release tablet
11/10/2004	CN1174996C Inhibitor and stimulator of stem cell proliferation and use thereof
11/10/2004	CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/10/2004	CN1174984C Carbamoyl tetrahydropyridine derivatives
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174979C Piperazine and piperidine compounds
11/10/2004	CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/10/2004	CN1174977C Pseudo polymorph of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one
11/10/2004	CN1174973C Schizonepeta lactone and its extraction process and use
11/10/2004	CN1174755C Method for preparing artificial bear bile powder
11/10/2004	CN1174753C Improved copolymer-1 composed of copolymers
11/10/2004	CN1174752C 核糖口服液 Oral ribose
11/10/2004	CN1174734C Shampoo compositions
11/09/2004	US6815557 Tryptase inhibitors
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815465 Heterocyclic compounds inhibiting angiogenesis
11/09/2004	US6815461 Method of inhibiting retroviral integrase
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815458 Nervous system disorders
11/09/2004	US6815456 Antiserotonine agents; central nervous system disorders
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815442 Quinoxalinones for enhancing chemotherapy
11/09/2004	US6815441 Reaction products of taurultam and glucose
11/09/2004	US6815440 For therapy and prophylaxis of disorders in the course of which is involved an increased activity of matrix-degrading metalloproteinases
11/09/2004	US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004	US6815427 Sericin-containing material, process for producing the same method of using the same
11/09/2004	US6815416 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/09/2004	US6815414 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	US6814958 Extract selected from the group of grape seed extract, a green tea extract, a blueberry extract and a silymarin extract; and at least one member selected from vitamin c and and vitamin e for treating periodontosis
11/09/2004	US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine.
11/09/2004	US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route
11/09/2004	CA2265824C Antifungal combination therapy
11/09/2004	CA2170047C Androstenone derivative
11/09/2004	CA2126195C Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094446A1 Remedies for diseases caused by strengthened vascular smooth muscle using 14-membered ring macrolide compounds
11/04/2004	WO2004094402A1 NOVEL SUBSTANCE HAVING α-GLUCOSIDASE INHIBITING ACTIVITY AND FOOD CONTAINING THE SAME
11/04/2004	WO2004094362A1 CaSR ANTAGONIST
11/04/2004	WO2004093911A1 Pharmaceutical composition for prostatic disease treatment
11/04/2004	WO2004093877A1 Vitamin comprising pyroloquinoline quinone and use thereof
11/04/2004	WO2004093873A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
11/04/2004	WO2004093858A1 Mmp expression inhibitor
11/04/2004	WO2004076349B1 Therapeutic malonic acid/acetic acid c60 tri-adducts of buckminsterfullerene and methods related thereto
11/04/2004	WO2004004652A3 Mitotic kinesin binding site
11/04/2004	WO2004003000A3 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
11/04/2004	WO2003090512A3 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/04/2004	WO2003089903A3 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
11/04/2004	WO2003086324A3 Preparation and use of a stable formulation of allosteric effector compounds
11/04/2004	WO2003078431A8 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
11/04/2004	WO2003060091A3 Selective melanin-concentrating hormone type -1 receptor agonists
11/04/2004	WO2003029420A3 Apo-2 ligand variants and uses thereof
11/04/2004	WO2003000183A3 Method of treating atherosclerosis and other inflammatory diseases
11/04/2004	WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220536 Apparatus with weeping tip and method of use
11/04/2004	US20040220396 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
11/04/2004	US20040220260 efficacious in producing nitric oxide in the skin, the mucous membranes or the scalp; treatment of psoriasis lesions and/or chronic ulcers; i.e. Ascorbyl 2-O-cinnamate
11/04/2004	US20040220257 modulating the activity of the mitochrondrial permeability transition pore complex comprising exposing said complex to compound such as Spiro [Cyclopentane-1,5'-[5H]Dibenzo [a,d]Cyclohepten]-2-one, 10', 11'-dihydro-3-methylene-
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220241 Substituted biphenyl derivatives
11/04/2004	US20040220238 Pyrrolidine oxadiazole-and thiadiazole derivatives
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220234 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220223 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
11/04/2004	US20040220213 Zolpidem hemitartrate
11/04/2004	US20040220212 Zolpidem hemitartrate
11/04/2004	US20040220211 Zolpidem hemitartrate
11/04/2004	US20040220210 therapy of insomia, sleep disorders
11/04/2004	US20040220209 Novel imidazopyridine compounds with therapeutic effect
11/04/2004	US20040220208 Imidazopyridinones as p38 map kinase inhibitors
11/04/2004	US20040220207 Chemokine receptor binding heterocyclic compounds

1 ... 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 ... 1564